Although, rheumatoid factor (RF) and/or anti-citrullinated protein antibody (ACPA), especially at high levels, have been shown to be associated with erosive disease and poor outcome in RA, they have not consistently been shown to predict response to a variety of bDMARDs [3]. This evidence concerns the gene PRTN3 and rheumatoid arthritis.